Moreover, O-GlcNAcylation is upregulated in some endometrial cancer cell lines and hyper-O-GlcNAcylation is associated with increased migration, a mesenchymal morphology and increased expression of the EMT marker N-cadherin. This evidence concerns the gene CDH2 and endometrial cancer.